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Abstract 
 
22q11.2 deletion syndrome (22q11DS) - a neurodevelopmental condition caused by a 
hemizygous deletion on chromosome 22 - is associated with an elevated risk of psychosis and 
other developmental brain disorders. Prior single-site diffusion magnetic resonance imaging 
(dMRI) studies have reported altered white matter (WM) microstructure in 22q11DS, but small 
samples and variable methods have led to contradictory results. Here we present the largest 
study ever conducted of dMRI-derived measures of WM microstructure in 22q11DS (334 
22q11.2 deletion carriers and 260 healthy age- and sex-matched controls; age range 6-52 
years). Using harmonization protocols developed by the ENIGMA-DTI working group, we 
identified widespread reductions in mean, axial and radial diffusivities in 22q11DS, most 
pronounced in regions with major cortico-cortical and cortico-thalamic fibers: the corona radiata, 
corpus callosum, superior longitudinal fasciculus, posterior thalamic radiations and sagittal 
stratum (Cohen’s d’s ranging from -0.9 to -1.3). Only the posterior limb of the internal capsule 
(IC), comprised primarily of corticofugal fibers, showed higher axial diffusivity in 22q11DS. 
22q11DS patients showed higher mean fractional anisotropy (FA) in callosal and projection 
fibers (IC and corona radiata) relative to controls, but lower FA than controls in regions with 
predominantly association fibers. Psychotic illness in 22q11DS was associated with more 
substantial diffusivity reductions in multiple regions. Overall, these findings indicate large effects 
of the 22q11.2 deletion on WM microstructure, especially in major cortico-cortical connections. 
Taken together with findings from animal models, this pattern of abnormalities may reflect 
disrupted neurogenesis of projection neurons in outer cortical layers. 
 
 
1. Introduction 
  
22q11.2 deletion syndrome (22q11DS; also known as Velocardiofacial or DiGeorge syndrome) 
results from a recurrent 1.5-3 megabase (Mb) microdeletion on the long arm of chromosome 22. 
It is the most common chromosomal microdeletion syndrome, with a prevalence of 1 per 3000 
to 4000 live births1,2. 22q11DS is associated with a range of characteristic abnormalities, 
including cardiac defects, craniofacial anomalies, and intellectual disability1,3. Particularly, it 
increases the risk for psychotic illness around 25-fold relative to the general population2,4–6. The 
deletion is also associated with elevated rates of other developmental neuropsychiatric 
disorders5, but the increased risk for psychosis in 22q11DS may be the most specific 
association, as it greatly exceeds the roughly 3-fold increased risk of psychosis associated with 
general developmental delay7,8. Notably, mouse models of the 22q11.2 deletion show fewer 
neural progenitors of projection neurons in cortical layers 2/3, which leads to altered connectivity 
between cortical association areas9. Hence, 22q11DS is a compelling model to study genetic 
causes and neural mechanisms underlying disorders of cortical circuit development such as 
schizophrenia. 
   WM microstructural properties can be quantified non-invasively in humans using dMRI. 
Fractional anisotropy (FA), a widely used measure of WM microstructural organization, is 
derived from a common dMRI reconstruction method, diffusion tensor imaging (DTI), and may 
reflect the coherence and density of fiber tracts in a voxel. Other DTI indices, axial diffusivity 
(AD) and radial diffusivity (RD), are also altered in a range of brain diseases10. For example, 
lower AD can reflect axonal damage and degeneration11, or reduced axonal diameter12. RD is 
associated with inter-axonal spacing (i.e., extracellular space)12; animal models, demyelination 
and dysmyelination can lead to abnormally high RD13–15. Mean diffusivity (MD), an average of 
radial and axial diffusivities, is a generalized measure of the surface-to-volume ratio of cellular 
membranes16. 
   Disturbances in WM microstructural organization have been frequently reported in 
22q11DS; however, studies to date have been relatively small, with highly variable findings. 
While many studies reported lower FA in 22q11DS compared to healthy controls (HC) in major 
WM tracts, including commissural, association and projection fibers17–22, several others reported 
higher overall FA23–25, or mixed findings across tracts26–31. Most studies reported consistent 
decreases in DTI-derived diffusivity measures (i.e., MD, RD, and AD), although some report 
mixed results20 or higher WM diffusivity in 22q11DS21,22. Supplementary Table S1 summarizes 
prior findings. These contrasting reports have hindered conclusions regarding the nature of WM 
microstructural abnormalities in 22q11DS. 
     Contrasting findings in prior studies may also be due to different analytical techniques, 
ranging from tract-based spatial statistics (TBSS32) to voxel-wise analyses and tractometry. This 
technical variability makes it difficult to apply traditional meta-analytic approaches that attempt 
to combine summary statistics from prior publications. 
   WM differences associated with psychosis are of interest in 22q11DS. Psychotic 
symptoms in 22q11DS have been associated with higher FA and lower WM diffusivities, but not 
always in the same regions across studies22,25,30,31,33,34. Additionally, there is variability in 
deletion breakpoints; 85-90% of individuals with the deletion have a ~3 Mb (A-D) deletion, 
containing 46 protein-coding genes, whereas ~10% of cases have a nested 1.5 Mb (A-B) 
deletion1. WM differences in 22q11DS may be due in part to variable deletion size, as deletion 
size impacts cortical surface area35. 
   To address these uncertainties and determine factors that affect WM abnormalities in 
22q11DS, the 22q11DS Working Group of the Enhancing Neuroimaging Genetics through 
Meta-analysis Consortium (ENIGMA-22q11DS) performed a coordinated analysis of the raw 
dMRI data from ten independent studies, and meta-analyzed group differences and their 
modulators. We addressed these questions: 
(1) Are there consistent group differences in WM microstructure between 22q11.2 deletion 
carriers and demographically-matched healthy controls? 
(2) Are there differential age effects between groups, suggesting altered WM development in 
22q11DS? 
(3) Do 22q11DS participants with a psychotic disorder show more severe WM alterations, and 
do these differences overlap with those found in idiopathic schizophrenia? 
(4) Does deletion size impact DTI indices? 
(5) Is WM microstructure related to cognitive abilities, in 22q11DS and in HC? 
 
2.Methods 
2.1. Participants 
dMRI data were contributed from ten studies previously acquired by the ENIGMA-22q11DS 
working group. This analysis included 594 participants: 334 with 22q11DS (mean age: 16.88 ± 
6.43, 153 females) and 260 healthy controls (HC; mean age: 16.55 ± 8.01, 123 females). 
Demographic characteristics are shown in Table 1 and Supplemental Table S2a-S2b. 
Psychotropic medication status at the time of scanning is included in Supplementary Table 
S2c. Individual study details are in Supplemental Table S3. Institutional review boards at 
participating institutions approved all study procedures, and material transfer agreements 
approved any sharing of de-identified imaging data. Written informed consent was obtained 
from all study participants or a legal guardian. 
  
2.2. Measurements of sample-specific phenotype characteristics 
  All sites conducted structured diagnostic interviews at the time of scanning to determine 
lifetime psychiatric diagnoses. Wechsler IQ assessments were used to assess cognitive 
function (Supplemental Table S3, Supplemental Methods 1). 
  Across sites, deletion size was determined using multiplex ligation-dependent probe 
amplification (MLPA)36. The large sample size here uniquely allowed for the comparison of 
effects of the two most frequent deletion types, the longer A-D vs. the shorter A-B deletion, on 
DTI measures. From cases with available MLPA data, 206 subjects had the A-D deletion 
(89.9%), and 15 (6.5%) subjects had the A-B deletion (see Supplemental Table S3). 
 
2.3. Image acquisition and processing 
Acquisition parameters of dMRI and T1-weighted MRI scans for each site are shown in 
Supplemental Table S4 and S5. All raw data were pre-processed in an identical fashion at a 
single site (Supplemental Methods 2). FA, MD, RD, and AD maps were skeletonized as 
described in the ENIGMA DTI protocol37,38, based on the TBSS method32, ensuring that all data 
are normalized to the ENIGMA-DTI template. Mean values were calculated for each DTI 
measure along the skeleton within each ROI defined by the Johns Hopkins University WM atlas 
(JHU-ICBM-DTI-81) distributed by FSL37,39. For all analyses, we used the mean of the right and 
left values for bilateral ROIs, for each measure; we included the mean of all WM JHU-ICBM 
ROIs and we excluded the corticospinal tract, fornix and cingulum of the hippocampus as these 
ROIs are difficult to reliably register40. The ROIs included are shown in Figure 1. 
 
2.4. Statistical Analyses 
2.4.1. Effects of 22q11DS and age on DTI-derived measures 
Group differences between 22q11DS and HC were investigated using two analytic approaches: 
a meta-analysis, which runs statistical comparisons for each site separately and combines the 
summary statistics across sites, and a mega-analysis, in which data are harmonized and pooled 
from individual subjects, and statistical analysis are run on the full group. The meta-analysis 
included 540 subjects: 278 22q11DS probands (mean age: 16.76 ± 6.78, 138 females) and 260 
HC (mean age: 16.55 ± 8.01, 123 females) from nine independent datasets derived from eight 
sites (Table 1). Because Utrecht included only 22q11DS cases, it was not included in the case-
control analyses. For each site, linear regressions were run, in which the mean DTI measure for 
each ROI was the dependent variable, diagnosis was the predictor of interest, and age, [age-
mean(age)]2 and sex were included as covariates. Given that DTI-derived measures tend to 
peak between 11 and 20 years for commissural and association fibers and in the early twenties 
for projection fibers41,42, we included both the linear and quadratic effects of age in the model. 
The quadratic age term was centered to avoid collinearities with the linear age term. In addition, 
because females and males show different trajectories of DTI measures across development43, 
sex was accounted for in the model. Cohen's d effect sizes for diagnosis were computed. 
Subsequently, an inverse-variance weighted mixed-effect meta-analysis44 to combine individual 
site effect sizes, as in40. 
A pooled, or mega-analytic, approach was also conducted. As multiple factors can affect 
the distribution of DTI measures45–47, additional harmonization of DTI measures can be 
advantageous when conducting studies pooling dMRI data from different protocols. We used 
the COMBAT algorithm48 to harmonize data across sites for each DTI measure (FA, MD, RD, 
AD) for each WM ROI. This algorithm uses an empirical Bayes framework to estimate additive 
and multiplicative site effects. It has been used previously for harmonization of multisite DTI 
data, and has been shown to perform better than several other methods for modeling and 
removing inter-site variability48. Next, group differences were assessed using the same model 
tested in the meta-analysis. Finally, the diagnosis-by-age interaction effect term was included in 
the mega-analytic model to test whether effects of age differed in 22q11DS probands relative to 
HC. 
We used the Benjamini & Hochberg method to control for the family wise error rate49.  
The percentage of tolerated false positives was 5% (q<0.05). Critical p-values were calculated 
for each set of models, specifically: (1) meta-analysis; (2) mega-analysis; and (3) mega-analysis 
including diagnosis-by-age interaction. Effect sizes were derived as explained in Supplemental 
Methods 3. 
 Additionally, given previous findings of non-linear trajectories of DTI-derived measures 
with respect to age in healthy individuals (5-82 years)50, we fit a Poisson non-linear model for 
age for each group separately (HC and 22q11DS) for each WM ROI and for each DTI-derived 
measure, to further investigate age effects. We used the previously harmonized data (see 
above COMBAT harmonization), to reduce site effects. We measured the age of peak FA and 
age of minimum MD, RD and AD as in Lebel et al.50 and compared both groups using a two-
tailed t-test for means with outlier removal (⍺=0.05). Thereafter, we calculated percent changes 
of each DTI-measure for each ROI from age 6 (minimum age in both groups) to peak/minimum, 
and from peak/minimum to age 46 and 52 (maximum age for 22q11DS and HC, respectively). 
We compared the percent changes of each DTI-measure for all ROIs between 22q11DS and 
HC groups by using Yuen’s method with bootstrap-t for trimmed means (⍺=0.05). 
 
2.4.2. Influence of psychotic disorder, deletion size and IQ on DTI measures 
    To assess potential differences in WM architecture as a function of clinical and genetic 
variability, we examined the effects of psychotic illness (35 with psychotic disorder vs. 191 
without psychosis) and deletion size (206 AD vs. 15 AB) on DTI measures, within individuals 
with 22q11DS. Additionally, given that IQ is a group-associated variable, we examined partial 
correlations with IQ within the 22q11DS (N=304) and HC groups (N=102) separately. For these 
analyses the DTI measures for each ROI were included as dependent variables.  Age, [age-
mean(age)]2 and sex were included as covariates. FDR correction was performed as specified 
above (section 2.4.1). 
  Given the strong association between age and psychosis onset5, as well as the 
differences in mean age between 22q11DS cases with and without psychosis (see 
Supplementary Table S2b), to assess the effect of psychosis within the 22q11DS group we 
used a local nonparametric ANCOVA method51 covarying for age (see Supplemental Methods 
4). This approach allowed for a controlled test within age subgroups. 
     Next, in order to determine whether the microstructural changes observed in 22q11DS-
associated psychosis overlap with those seen in idiopathic schizophrenia, we compared our 
results for 22q11DS cases with and without psychosis to schizophrenia case-control results 
from the ENIGMA-Schizophrenia DTI Working Group40, analyzed using the same protocols as in 
our study. 
 
3. Results 
3.1. Group differences across sites 
     We first investigated whether there were consistent group differences in WM microstructure 
between 22q11.2 deletion carriers and healthy controls, using a  standardized processing 
pipeline. Equally important is to determine whether harmonization of the data would allow 
pooled analyses for further investigation of modulatory factors (psychosis, deletion size, and 
IQ). Figure 2 shows group differences for 22q11DS cases vs. HC, from the meta-analysis and 
mega-analysis: results were nearly identical, with similar effect sizes. Effect sizes for each site 
are shown in Supplementary Figure 1. Most ROIs that significantly differed between 22q11DS 
and HC showed lower diffusivity values (MD, AD and RD) in 22q11DS subjects, but a mixed 
pattern for FA. Significantly higher FA in 22q11DS cases relative to HC was observed in the 
tapetum (TAP), genu (GCC), body and splenium of the corpus callosum (BCC/SCC), the 
anterior and posterior limb of the internal capsule (ALIC/PLIC), and posterior and superior 
corona radiata (PCR/SCR), with moderate to large effect sizes (d~0.3-0.8), for both analyses. In 
contrast, ROIs in association fibers - the superior longitudinal fasciculus (SLF), fornix/stria 
terminalis (FXST), and external/extreme capsules (EC) - showed significantly lower FA in 
22q11DS relative to HC (Supplementary Tables S6-S7). 
  22q11DS subjects had significantly lower MD than HC in almost all ROIs investigated, 
with greatest effects (d~1.0) in the PCR and posterior thalamic radiation (PTR); both contain 
mostly thalamocortical/corticothalamic and corticofugal fibers from posterior brain areas. For all 
18 ROIs, MD was lower in 22q11DS, as was AD, for 15 of the 18 ROIs. Only the PLIC showed 
significantly higher AD in 22q11DS relative to HC. For RD, all ROIs showing significant 
differences (15 of 18 ROIs) were lower in 22q11DS than HC, with largest effects (d~0.7) in the 
corpus callosum and PCR (Supplementary Tables S6-S7). 
 
3.2. Age-associated effects 
     Given the wide age range (6-52 years), we wanted to determine whether the development of 
WM is delayed or altered in 22q11DS. As shown in Supplementary Table S6, there were 
highly significant linear effects of age for all indices for the majority of ROIs. FA increased with 
age, while the opposite pattern was found for diffusivity values (MD, AD and RD). There were 
also significant quadratic effects for almost all ROIs for FA, MD and RD. AD showed fewer 
significant quadratic effects, in both the meta- and mega-analysis. However, no significant age-
by-diagnosis interactions were observed (Supplementary Table S8). Given the sparse 
representation of older adults, we also performed a mega-analysis with a subsample of subjects 
under 30 years old to explore potential age-by-diagnosis effects, which yielded similar results 
(Supplementary Table S9). 
We also investigated Poisson regression models to further evaluate effects of age on 
WM development. These models did not provide a  substantially better fit to the data than the 
linear regression model used above, as determined by the residual standard error of the fits 
(see Supplementary Tables S10, S11, S12). As such, we retained the linear regression 
models for our primary analyses, but report the additional trajectory information obtained from 
the Poisson models below.  
Scatterplots for the non-linear Poisson fits of age per ROI for each DTI-derived measure 
are displayed in Supplementary Figures S2-S5. There were fewer ROIs with significant 
peak/minimum estimates in the 22q11DS group, across all DTI indices (see Supplementary 
Tables S13, S14). Generally, those ROIs without significant peak/minimum estimates have 
linear rather than exponential growth and decay trajectories. When comparing the mean age of 
peak FA (across ROIs) between HC and 22q11DS, average peak FA was significantly delayed 
in 22q11DS. We found significantly delayed mean age at minimum RD in 22q11DS, but no 
differences in minimum MD and AD. Mean rate of FA decrease (after peak FA), and mean rate 
of increase in RD and MD (after minimum RD/MD), were also significantly greater in HC vs. 
22q11DS, with no differences in AD (Supplementary Table S15). 
 
3.3. Influence of psychosis 
    Are the deletion-related WM changes more severe in those with psychotic disorder? Relative 
to 22q11DS subjects without psychosis, 22q11DS subjects with psychotic disorder showed 
overall lower diffusivity values, with significantly lower AD in the ALIC and PTR, both 
predominantly containing thalamic radiation fibers, in the cingulum of the cingulate gyrus (CGC) 
and the SLF, which mostly contain fronto-parietal and fronto-temporal association fibers, and 
the sagittal stratum (SS), which contains both posterior thalamic projection and temporal 
association fibers.  22q11DS-Psychosis was also associated with significantly lower RD and MD 
in the GCC, which contains callosal fibers, and significantly lower MD in the PLIC, where the 
superior thalamic radiation and cortico-pontine fibers are the major constituents.  These 
differences were seen primarily between ages 20 and 26 for most ROIs; some ROIs (ALIC, PTR 
and SS) showed differences by age 16-17 (Figure 3 and Supplementary Table S16). Overall, 
these findings confirm that WM changes detected by DTI diffusivity measures are more severe 
in 22q11DS patients with psychotic disorder, and are particularly evident in young adulthood.     
 
3.4. Comparison of WM Microstructure in 22q11DS-Psychosis to Idiopathic Schizophrenia 
    Next, we compared our results for 22q11DS cases with and without psychosis to 
schizophrenia case-control results (2359 HC vs. 1963 schizophrenia patients)40, plotted together 
for visualization purposes (Figure 4). Effects for 22q11DS cases with and without psychosis 
differed markedly from those observed for idiopathic schizophrenia relative to HC. Specifically, 
while patients with 22q11DS-psychosis tended toward higher FA and lower diffusivity values 
compared to 22q11DS individuals without psychosis, patients with idiopathic schizophrenia 
showed overall lower FA across tracts and increased diffusivity values relative to HC, 
particularly for MD and RD.   
 
3.3. Influence of deletion type and IQ 
       Does the extent of the deletion affect WM microstructure? Subjects with the large A-D 
deletion showed a trend toward lower AD in the anterior corona radiata (ACR) and EC, and 
higher FA in the TAP; however, there were no statistically significant differences as a function of 
deletion size, after multiple comparison correction (see Supplementary Figure S6 and 
Supplementary Table S17).   
Additionally, regarding relationships between DTI indices and cognitive abilities, healthy 
controls showed trends toward positive correlations of MD, RD and AD in multiple ROIs with IQ, 
and a trend toward an inverse correlation of FA with IQ in the TAP. Within 22q11DS cases, 
findings were similar, but higher IQ was associated with significantly higher AD in the PTR, 
which contains mainly posterior cortico-thalamic and thalamo-cortical fibers. There was also a 
trend toward higher AD in average WM, genu of the CC, and SS being associated with higher 
IQ in 22q11DS (Supplementary Figure S7, Supplementary Table S18). While these 
relationships were not significant when corrected for multiple comparisons, the overall pattern of 
findings suggests that relationships between WM microstructure and cognition may differ in 
22q11DS relative to typically developing controls.  
 
4. Discussion 
       This is the largest study to date of WM microstructure in 22q11DS (334 22q11DS cases 
and 260 HC), assessed by DTI. Our analysis pipeline37,40 allowed for coordinated prospective 
meta- and mega-analyses of the data across sites, unlike traditional meta-analyses that 
combine statistical results from the literature. This approach addresses, for the first time, issues 
of low power due to small sample sizes and variable analysis protocols that contribute to 
heterogeneity and lack of clarity in DTI studies to date. 
In contrast to findings in many neuropsychiatric disorders40,52, our findings revealed 
overall lower DTI diffusivities (AD, RD and MD) in 22q11DS compared to HC, with regionally 
varying directions of effect for FA. Higher FA, lower RD and AD (and consequently, lower MD) 
appear to be the hallmark of microstructural alterations in the major WM tracts in 22q11DS, 
especially in the commissural fibers of the corpus callosum. While this may suggest greater 
myelination13, we must be cautious in applying this interpretation to our findings, given that 
dMRI cannot directly index the degree of myelination53. Anisotropy does not only depend on the 
presence of myelin in the WM, as it  has been demonstrated in unmyelinated tracts54 and is also 
sensitive to axonal density. RD is sensitive to axonal density and amount of extracellular space, 
and AD to axonal diameter and organization12,55. Moreover, since axonal density and 
myelination are correlated54,56, it is not possible to disentangle one from another when 
interpreting FA and RD differences between populations. We postulate that the observed group 
differences may result from an increase in the cumulative cellular membrane circumference57 in 
22q11DS (attributable to differences in axon composition, myelination and/or reactive 
astrocytes), which hinders diffusion perpendicularly to the WM tracts, hence increasing 
anisotropy and decreasing RD. 
Our findings of higher FA in 22q11DS relative to controls in ROIs in commissural tracts 
(TAP, GCC, BCC, SCC), no detectable differences in ROIS where projection fibers predominate 
(RLIC, SS, PTR, SFO), and lower FA in ROIs in long association tracts (EC, SLF, FXST) are 
consistent with findings in the mouse model of 22q11DS9. Specifically, this study found that 
proliferation of basal, but not apical progenitors is disrupted, and subsequently the frequency of 
projection neurons in layers 2/3, but not layers 5/6, is altered. Commissural and long association 
fibers originate primarily from projection neurons, i.e., pyramidal neurons in the outer layers 2/3, 
whereas corticofugal and cortico-thalamic projection fibers tend to originate from pyramidal cells 
in cortical layers 5/6.  Moreover, our results suggest that the nature of WM disruptions may 
differ between callosal and long association fibers in 22q11DS, but advanced microstructural 
MRI techniques may be necessary to disentangle these differences. As such, these cross-
species findings collectively suggest a potential neurobiological model in which 
haploinsufficiency at the 22q11.2 locus leads to disruptions of specific aspects of early brain 
development, and subsequent changes in neural circuitry that likely elevate risk for 
neuropsychiatric disorders in 22q11DS patients. 
We speculate that our findings may be related to three types of histopathological 
alterations in WM of 22q11DS patients, all of which could reduce diffusivity. First, a recent 
neuropathology study of a 3-month old infant with 22q11DS reported decreased neuronal 
frequencies in outer cortical layers and increased neuronal frequencies in deeper cortical 
layers9. This is closely related to findings in the LgDel 22q11.2 mouse model mentioned above9. 
Pyramidal neurons of cortical layers 2/3 generate a substantial portion of the cortico-cortical 
axonal projections between association areas58. These axons are present in most of the WM 
ROIs included in this study. Consequently, target-to-origin signaling between cortical 
association areas (cortico-cortical projections) may be disrupted in 22q11DS, affecting the 
necessary cues to initiate proper axonal differentiation59,60, ultimately affecting the development 
of a typical distribution of axonal diameters61–63, and therefore altering RD and AD in WM 
bundles. Moreover, the PLIC was the only ROI showing higher AD in 22q11DS. AD has been 
associated with axonal diameter changes and axonal tortuosity in rats12,55. PLIC is the only ROI 
in this study that contains mostly corticofugal fibers, which primarily derive from cortical layers 
5/639,58, suggesting that the axonal size distribution within fiber bundles originating in the deeper 
cortical layers may differ from those originating in the outer cortical layers61,63. Further studies of 
animal models and post-mortem human brain tissue may shed light on this. 
    Second, DTI abnormalities may also reflect gliotic changes secondary to microvascular 
insults. Post-mortem findings in 22q11DS adults indicate both deep WM gliosis associated with 
cerebrovascular changes64. Gliosis - occurring as brain reacts to microvascular injuries - has 
been associated with increased anisotropy in a mouse brain injury model65. Third, DTI 
measures may be affected by ectopic neurons in WM that may result from neuronal migration 
defects during early development66. These have been reported in both neuropathologic64,67,68 
and neuroimaging studies of 22q11DS patients69,70. While we did not detect any heterotopias in 
our cohort, subtle microscopic ones may be detected only via histology. 
The age trajectories of FA MD, RD and AD, as well as peak and minimum age estimates 
of our control sample, were similar to those reported previously50. However, 22q11DS patients  
showed a delayed mean age of both peak FA and minimum RD; correspondingly, they also 
showed lower decrease and increase rates for FA and MD after peak and minimum ages, 
respectively. As noted above, these findings may indicate a delay in maturation secondary to 
altered axonal diameters and organization in the deep WM, which could be precursors of a 
delayed myelination process. Conversely, lower rate of change after maturation (indicated by 
peak FA and minimum RD) may be indicative of underlying organizational changes in WM that 
abnormally hinder diffusion and may result from gliotic changes, as has been reported in adult 
post-mortem 22q11DS brain tissue64. Nevertheless, despite the harmonization protocol 
interpretive caution is warranted because the age distribution was variable across  sites and 
data points were rather sparse in the higher age ranges.  
Consistent with some single-site studies suggesting inverse correlations between 
psychotic symptom severity in 22q11DS and diffusivity in the CC and long association 
tracts25,29–31,33, we found lower RD and MD in those with psychosis in the genu of the CC, and 
lower axial diffusivity in long association tracts such as the SLF and CGC. Interestingly, 
significantly lower AD was found in ROIs with predominantly cortico-thalamic and thalamo-
cortical fibers such as the ALIC, SS and the PTR. A previous single-site tractometry study found 
significant associations between higher FA and lower RD in the ALIC with positive prodromal 
symptoms29. Future studies should prospectively investigate the role of the major thalamic 
projection tracts in the emergence and progression of psychotic symptoms in 22q11DS.  
Notably, WM microstructural alterations in 22q11DS with psychosis showed a largely 
opposite pattern from those seen in idiopathic schizophrenia, involving primarily FA increases 
rather than decreases and reductions (rather than increases) in diffusivity measures. A previous 
single site study of 22q11DS and youth at clinical high risk for psychosis reported this 
directionally opposite pattern as well24. This is in contrast to findings for cortical gray matter, in 
which 22q11DS patients with psychosis showed highly significant overlap with idiopathic 
schizophrenia, in terms of prominent cortical thinning in fronto-temporal regions35. Thus, our 
findings suggest that patterns of neuroanatomic overlap in 22q11DS-associated vs. idiopathic 
psychosis markedly differ for gray and WM, and suggest that different WM phenotypes may 
lead to similar downstream clinical outcomes. Our findings of altered AD in 22q11DS, more 
extreme in those with psychosis, may indicate altered axonal diameter and increased tortuosity 
of WM tracts12,55. Numerous smaller, tortuous axons in key connections between cortical 
association areas may lead to altered WM maturation, structural dysconnectivity and possibly 
psychosis. In idiopathic schizophrenia, WM degeneration (demyelination and loss of axons with 
larger diameters) may also lead to disrupted axonal morphology that similarly results in 
structural dysconnectivity between cortical association areas. 
We did not see consistent effects of deletion size on WM architecture, and found little 
evidence that the relationship between WM microstructure and IQ differed between 22q11DS 
cases and HC. Sample size was quite limited for the A-B deletion type, and imaging protocols 
varied across sites, which may have affected our results. Additionally, given highly variable 
psychotropic medications and medical comorbidities in 22q11DS patients, their effects could not 
be systematically investigated here. Previously, in a sample including many of the same 
participants as in the current analysis, we found that psychotropic medication was not 
significantly associated with cortical thickness or cortical surface area in 22q11DS patients35. 
Additionally, prior studies of patients with idiopathic schizophrenia found that WM changes 
detected by DTI were not attributable to antipsychotic medication40,71. 
Future studies with multi-shell acquisitions and novel biophysical models may resolve 
the contribution of the intra- and extra-axonal volume fractions and axonal diameters to these 
abnormalities72,73. Quantitative magnetization transfer74 and perfusion MRI acquisitions75 may 
help clarify any myelin abnormalities or underlying brain microvascular pathology in 22q11DS. 
  Collectively, our findings indicate large effects of the 22q11.2 deletion on WM 
microstructure. Diffusivity was more consistently affected than FA. In animal models, disruptions 
to predominantly cortico-cortical and cortico-thalamic/thalamo-cortical connections in 22q11DS 
may be attributable to disrupted early neurogenesis. Future translational studies will help to 
determine the neurobiological underpinnings of these alterations.  
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Table 1. Demographic information of study participants. Demographic information of study 
participants, per site. SD = standard deviation; M = Male; F = Female, HC = Healthy Controls. 
(1) University of Pennsylvania/Children's Hospital of Philadelphia (PA, USA); (2) University 
California Los Angeles (CA, USA); (3) State University New York Upstate (NY, USA); (4) 
University of Newcastle (NSW, Australia); (5) Maastricht University (Netherlands); (6) Institute of 
Psychiatry (London, UK); (7) University California Davis #1 (CA, USA); (8) University California 
Davis #2 (CA, USA); (9) Cardiff Univ. (WAL, UK); (10) Utrecht Univ. (The Netherlands). 
 
 
 
 
Figure captions (in order of appearance below) 
 
Figure 1. Depiction of the 18 regions of interest (ROIs) of the Johns Hopkins University (JHU-
ICBM) white matter atlas [Mori et al. (2008)] that were analyzed in the present study. 
 
Figure 2. Results of meta- and mega-analysis including nine independent datasets from the 
ENIGMA-22q11DS working group. The bar graphs on the left side are organized based on the 
effect sizes for FA (positive to negative, from left to right). The brain maps on the right side are 
organized by rows, each one corresponding to respective bar graph on the left. These show the 
JHU-ICBM atlas white matter ROIs that passed multiple comparison correction after meta-
analysis.The model tested was: 
DTI-ROI-measure=ß0 + ß1Diagnosis+ß2Sex+ß3Age+ß4Age2centered. 
WM = Average of all white matter JHU-ICBM ROIs. 
 
Figure 3. Results from the local nonparametric ANCOVA analysis comparing 22q11DS subjects 
with psychotic disorder (N=35) vs. those with no lifetime history of psychotic symptoms 
(N=191). Shown here are the results for DTI indices that significantly differed between 22q-
Psychosis vs. 22q-No Psychosis: AD in the ALIC, CGC, PTR, SLF and SS,  RD in GCC, and 
MD in the GCC and PLIC. All analyses were performed on 25 design points corresponding to 
different age bands. Vertical red lines correspond to the ages at which these DTI measures (AD, 
MD, RD) significantly differed between subjects with 22q11DS with and without psychosis.  
 
Figure 4. Comparison of Effect Sizes in this study, to those from the ENIGMA-Schizophrenia 
DTI Working Group using similar methods (2,359 healthy controls vs. 1,963 schizophrenia 
patients from 29 independent studies; Kelly et al. 2018; blue triangles) to 22q11DS probands 
with and without psychosis (red circles). Positive effect sizes: 22q-Psychosis > 22q-No 
Psychosis OR Schizophrenia Patients > Healthy Controls. Negative effect sizes: 22q-No 
Psychosis > 22q-Psychosis OR Healthy Controls > Schizophrenia Patients. 
 
 
 
 
 
 
  
Table 1. Demographic information of study participants. Demographic information of study participants, per site. SD = standard deviation; M 
= Male; F = Female, HC = Healthy Controls. (1) University of Pennsylvania/Children's Hospital of Philadelphia (PA, USA); (2) University 
California Los Angeles (CA, USA); (3) State University New York Upstate (NY, USA); (4) University of Newcastle (NSW, Australia); (5) 
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  Healthy Controls (HC) 22q11.2 DS  
Site N N (% by Sex) 
Mean Age 
(SD) 
Mean IQ 
(SD) 
N N (% by Sex) 
Mean Age 
(SD) 
Mean IQ (SD) Group Differences 
UPenn 49 
30 (61.2%) M; 
19 (38.8%) F 
17.31 
(3.22) 
— 43 
26 (60%) M; 
17 (40%) F 
17.49 (3.13) 77.16 (10.96) 
Age: t = 0.27 (p = 0.79) 
Sex: X2 = 0.01(p = 0.94) 
IQ:   NA 
UCLA 32 
16 (50%) M; 
16 (50%) F 
12.59 (5.62) 
111.97 
(21.69)  
49 
25 (51%) M; 
24 (49%) F 
14.69 (5.59) 76.55 (12.61) 
Age: t = 1.60 (p = 0.11) 
Sex: X2 = 0.02(p = 0.89) 
IQ: t = -9.11 (p < 0.0005) 
SUNY Upstate 11 
5 (45.45%) M; 
6 (54.5%) F 
21.12 (2.01) 
87.77 
(16.25) 
34 
19 (55.8%) M; 
15 (44.11%) F 
20.85 (1.86) 78.31 (13.72) 
Age: t = -0.43 (p = 0.67) 
Sex: X2 = 0.49(p = 0.48) 
IQ: t = -1.99 (p = 0.06) 
University of 
Newcastle 
17 
8 (47.1%) M; 
9 (52.9%) F 
17.06 (3.01) 
106.63 
(17.58) 
16 
6 (37.5%) M; 
10 (62.5%) F 
16.63 (2.75) 72.63 (13.45) 
Age: t = -0.43 (p = 0.67) 
Sex: X2 = 0.31(p = 0.58) 
IQ: t = -6.14 (p<.0005) 
Maastricht 
University 
36 
23 (63.8%) M; 
13 (36.2%) F 
29.97 
(10.05) 
105.13 
(14.13) 
24 
11 (45.9%) M; 
13 (54.1%) F 
30.05 (7.86) 
74.42 
(9.76) 
Age: t = 0.04 (p = 0.97) 
Sex: X2 = 1.91(p = 0.17) 
IQ: t = -8.14 (p<.0005) 
Institute of 
Psychiatry 
London 
24 
10 (41.7) % M; 
14 (58.3%) F 
18.36 
(6.73) 
115.92 
(15.03) 
24 
13 (54.1%) M; 
11 (45.9%) F 
18.04 (6.88) 84.46 (14.15) 
Age: t = -0.16(p = 0.87) 
Sex: X2 = 0.75(p = 0.39) 
IQ: t = -7.47 (p<.0005) 
  
UC Davis #1 36 
19 (52.7%) M; 
17 (47.3%) F 
10.22 
(2.38) 
116.06 
(10.69) 
31 
16 (51.6%) M;  
15 (48.4%) F 
10.86 (2.14) 73.60 (14.41) 
Age: t = 1.14 (p = 0.26) 
Sex: X2 = 0.01(p = 0.92) 
IQ: t = -13.23 (p<.0005) 
UC Davis #2 41 
20 (48.8%) M; 
21 (51.2%) F 
11.05 
(2.33) 
115.16 
(15.75) 
46 
21 (45.7%) M; 
25 (54.3%) F 
11.64 (2.53) 74.76 (13.83) 
Age: t = 1.11(p =. 027) 
Sex: X2 = 0.09 (p = 0.77) 
IQ: t = -12.45 (p<.0005)  
Cardiff 14 
6 (42.9%) M; 
8 (57.1%) F 
14.46 
(1.79) 
105.25 
(9.55) 
13 
6 (46.2%) M; 
7 (53.8%) F 
16.03 (4.63) 80.92 (19.30) 
Age: t = 1.18 (p = 0.25) 
Sex: X2 = 0.03 (p = 0.86) 
IQ: t = -3.91 (p = 0.001) 
Utrecht — — — -- 54 
38 (70.3%) M; 
16 (29.7%) F 
17.52 (4.22) 
69.24 
(7.66) 
NA 
Total 260 
137 (52.6%) M; 
123 (47.3%) F 
16.55 
(8.01) 
111.62 
(16.16) 
334 
181 (54.1%) M; 
153 (45.8%) F 
16.88 
(6.43) 
75.14 
(12.79) 
Age: t = 0.55 (p = 0.57) 
Sex: X2 = 0.04 (p = 0.5) 
IQ: t = 25.9 (p = 4.0e-79) 
 




